Eagle went to Boston!
Did you attend the presentation by Dr. Ross A. Caputo, Ph.D. at the Compounding Pharmacy Compliance Congress, where he discussed achieving Category 3 Beyond-Use Dates?
If you have questions about any of the Category 3 BUD requirements, make sure to visit our Eagle Team representatives: Lisa Johnson, Jacqueline Esqueda, PharmD, BCSCP, RPh, and Steve Kummer.
They are here to help you!
Event Information | Presentation Clip
Eagle is a U.S. Food and Drug Administration (FDA) and Drug Enforcement Agency (DEA) registered A2LA ISO 17025 accredited laboratory founded in 2003 that provides analytical chemistry and microbiological testing, consultation services, and other technical services for pharmacies, highly regulated industries, and research organizations to support their compliance needs.
Latest posts by Eagle Analytical (see all)
- Antimicrobial Effectiveness | USP 795 & 797 Revisions - July 18, 2023
- 2023 PDA/FDA Joint Regulatory Conference, 09/18 – 09/20 - July 11, 2023
- APC: Compounders on Capitol Hill, 09/19 – 09/20 - July 11, 2023
